Skip to nav Skip to content

2645 article(s) found

Study Aims To Improve Outcomes of Metastatic Colorectal Cancer

New trial is comparing standard treatment to a new bispecific antibody plus chemotherapy

EIPCM Cohort 3

Moffitt Program Helps Faculty Strengthen the Science of Mentorship

Redefining mentorship for the next generation of cancer researchers

graphic image of a lung scan with exaggerated cancer cells in the lungs

Two Phase 3 Trials Show New Treatment Paths for Different Non-Small Cell Lung Cancer Types

Selpercatinib lowers recurrence after surgery for RET fusion tumors; ivonescimab extends survival in advanced squamous disease

a man sitting on a couch across from a doctor holding a chart

Could Adding a Targeted Therapy Before Surgery Change Prostate Cancer Care?

Phase 3 trial suggests apalutamide with hormone therapy and surgery extends time before high risk prostate cancer returns or spreads

Study Tests Immune-Boosting Approach for Advanced Lung Cancer

Researchers are studying a new drug combination for patients with advanced non-small cell lung cancer who have limited treatment options after immunotherapy

Weight Loss Study Highlights Quality-of-Life Benefits for Breast Cancer Survivors

New findings suggest lifestyle interventions may improve physical function, fatigue and mental well-being long after treatment ends

Could Novel Breast Cancer Immunotherapy Reduce Need for Chemotherapy?

Study shows dendritic cell therapy enhances immune response in HER2-positive breast cancer

Could Fasting Around Chemotherapy Improve Ovarian Cancer Treatment?

Study suggests short-term fasting may help boost chemotherapy response in patients with advanced ovarian cancer

Kenny Bennett was diagnosed with a malignant peripheral nerve sheath tumor (MPNST), a rare and aggressive type of soft tissue sarcoma that develops in the protective cells covering peripheral nerves. 

Former Bucs Player Surprises Fan With Rare Cancer

Personalized message from Lavonte David inspires Kenny Bennett to keep fighting